- News Press Release | PharmiWeb.com
Press Release | www.pharmiweb.com | 18 hours 5 minutes ago
LONDON, November 26 /PRNewswire/ -- Rambeaux joined a host of other industry leaders at eyeforpharma's 9thannual Pharma Marketing Summit 2009 conference in Berlin, where several keythemes concerning market access and industry change emerged: - Transf
http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=11419
Novartis Cuts Ribbon on Cell-Culture Flu Vaccine Facility
Press Release | www.pharmamanufacturing.com | Nov 25, 2009
Novartis officially inaugurated the US's first-ever large-scale flu cell culture vaccine and adjuvant manufacturing facility in Holly Springs, North Carolina.
http://www.pharmamanufacturing.com/industrynews/2009/199.html?CMP=ILC-rss
FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review
Press Release | www.prnewswire.com | Nov 24, 2009
This new higher dose formulation contains 23 mg of donepezil HCl in an extended release, matrix-type tablet with a delivery system that allows for gradual release of the drug.
New Pharmaceuticals Antidepressants research report from Datamonitor
Press Release | www.prlog.org | Nov 24, 2009
New Pharmaceuticals Antidepressants research report from Datamonitor. Fast Market Research recommends "Commercial Insight: Antidepressants - Novel mechanism offers hope in depressed market" from Datamonitor, now available
The M&A Trend Continues: An Analysis of the Key Mergers and Acquisitions of 2009
Press Release | www.frost.com | Nov 23, 2009
The biggest mergers and acquisitions witnessed so far in 2009 have been the Pfizer-Wyeth acquisition for $68 billion, Roche-Genentech $46.8 billion, Merck-Schering Plough $41B and Gilead Sciences-CV Therapeutics $1.4B. This accounted for a total of $157 billion dollars.
http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=185479087
U.S. Court of Appeals Upholds AstraZeneca AWP Settlement (PR Newswire)
Press Release | finance.yahoo.com | Nov 21, 2009
BOSTON, Nov. 20 /PRNewswire/ -- The United States Court of Appeals for the First Circuit upheld an earlier District Court ruling yesterday, approving a settlement
http://finance.yahoo.com/news/US-Court-of-Appeals-Upholds-prnews-464568436.html?x=0&.v=1
Video: CRESTOR(R) Reduced Risk of Cardiovascular Events in Women by Nearly Half in New Analysis of JUPITER Study
Press Release | multivu.prnewswire.com | Nov 17, 2009
ORLANDO, Fla., Nov. 17 /PRNewswire/ -- A new analysis of 6,801 women in the JUPITER study showed CRESTOR (rosuvastatin calcium) 20 mg significantly reduced cardiovascular (CV) events (defined as the combined risk of myocardial infarction, stroke, arterial revascularization, hospitalization
Medical News: FDA Panel to Vote on Updated Strep pneumoniae Vaccine - in Pediatrics, Vaccines from
Press Release | www.medpagetoday.com | Nov 17, 2009
WASHINGTON -- A Food and Drug Administration (FDA) advisory panel will decide Wednesday whether to recommend approval of a new version of the popular Streptococcus pneumoniae children's vacci
Abbott to Develop New Heart Failure Test on ARCHITECT® Immunochemistry Diagnostics Platform
Press Release | www.abbott.com | Nov 17, 2009
Abbott to Develop New Heart Failure Test on ARCHITECT® Immunochemistry Diagnostics Platform
http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0796.htm?referrer=RSS
Hormone Therapy Victims Win Important Appeal
Press Release | www.prweb.com | Nov 11, 2009
PR: On November 2, 2009, the United States Court of Appeals for the Eighth Circuit issued its long-awaited decision in Scroggin v. Wyeth (Case No. 08-2555). The decision gives the green light for federal trials on Wyeth’s and Pfizer’s hormone therapy drugs. In affirming judgment on a jury ve
http://www.prweb.com/releases/hormone-therapy/hrt-lawsuit/prweb3188274.htm
